血液造血干细胞基因治疗神经代谢性溶酶体储存疾病的基因治疗
Giulia Consiglieri1, Francesca Tucci1, Maria Ester Bernardo2
1Pediatric Immunohematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, Italy.
Brain & development
|June 26, 2025
概括
造血干细胞原始细胞基因疗法 (HSPC-GT) 为罕见的神经代谢疾病提供了一个有前途的新疗法. 这种创新方法利用患者自己的细胞提供治疗基因,解决其他治疗方法不足的未满足需求.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 神经代谢障碍是影响大脑功能的遗传性单一性疾病.
- 这些渐进性疾病往往在生命早期表现出来,导致严重的中枢神经系统干扰.
- 目前的治疗方法,如酶替代疗法和干细胞移植,都有局限性,造成严重的疾病负担.
研究的目的:
- 对神经代谢障碍的造血干细胞原生细胞基因疗法 (HSPC-GT) 的最新进展进行审查.
- 突出HSPC-GT作为解决未满足医疗需求的新型治疗策略.
- 总结最近在这个快速发展的领域的发展和临床试验进展.
主要方法:
- 使用病毒载体对自身造血干细胞 (HSPC) 进行ex-vivo遗传修饰.
- 在化疗后将转基因HSPC注入患者体内.
- 改造HSPC的植入和分化,以产生功能治疗酶.
主要成果:
- 修改后的HSPC可以在正常或超正常水平上植入并产生治疗酶.
- HSPC-GT正在证明各种神经代谢疾病的临床试验活动越来越多.
- 几种HSPC-GT产品最近获得了市场批准,这表明它们具有治疗潜力.
结论:
- HSPC-GT代表了治疗神经代谢障碍的重大进展.
- 这种基因治疗方法为那些选择有限的患者提供了潜在的治疗策略.
- 扩大的临床应用和最近的批准强调了HSPC-GT的前景.
相关概念视频
Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K


